Source - SMW
JP Morgan Cazenove today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and set its price target at 1667p.

Related Charts

GlaxoSmithKline (GSK)

-1.50p (-0.10%)
delayed 17:15PM